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INTRODUCTION 
 
 Brassinosteroids (BRs) represent a recently recognized class of 
phytohormones that regulate a wide range of physiological functions 
throughout the life of plants from germination to seed production. 
Although intense studies of BR action started only following the 
middle of the 1990s, as a result of these investigations BR 
perception and signaling became one of the best known 
mechanisms of plant hormone regulation. It was established that 
BRs are perceived by cell surface-localized receptors which, in 
cooperation with their co-receptors, initiate a phosphorylation-based 
intracellular signaling process. This alters, via two closely related 
BR-specific transcription factors, the expression of a set of BR-
controlled genes. 
 Whereas the key components of BR perception and their roles 
were elucidated in detail, little information was available on their 
distribution within the plant. Based on early studies it was proposed 
that the receptor is expressed without spatial or other differential 
regulation, and that site- or development-specific BR effects depend 
only on local concentrations of the hormone. But this model was 
challenged by other results, obtained partly in our laboratory, which 
seemed to indicate organ-specific or time of the day- and light-
dependent differences in BR sensitivity. In particular, root 
development was known to be inhibited by BR concentrations that 
were enhancing the growth of aerial organs. Light-grown seedlings 
were found less susceptible to treatment by externally applied BRs  
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 than those grown in the dark. This could be evidenced by their 
different elongation responses, but also by the enhanced 
transcriptional reactions of BR-responsive genes upon dark 
treatment. 
 Therefore, the aim of our project was to find out whether the 
expression of the BR receptor BRI1, a key component in the 
signaling process that interacts with the hormone and initiates the 
phosphorylation cascade, is differentially regulated, and if so, 
whether this control mechanism can influence receptor distribution 
and alter BR susceptibility. For this work the model plant Arabidopsis 
was ideally suited, because its BR receptor, co-receptors and 
signaling components were well characterized, and several mutants 
in these elements were available. Among these particularly useful 
was the severely BR insensitive bri1-101 mutant that is devoid of 
functional BR receptor. We expected that by finding answers to the 
questions related to receptor expression and abundance we can 
contribute to the better understanding of the ways how BR sensitivity 
is modulated. Additionally, our results might also be useful for 
elucidating whether such adjustments are coordinated with the local 
levels of the hormone in order to evoke optimal physiological effects. 
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OBJECTIVES 
 
 Earlier results of our laboratory indicated increased BR sensitivity 
of Arabidopsis seedlings upon prolonged dark treatment (Bancos et 
al., 2006). This suggested that, in addition to BR levels, physiological 
responses to the hormone are also influenced via differential 
regulation of susceptibility. A highly specific, non-redundant element 
of BR signaling is the BRI1 receptor, which interacts directly with the 
hormone, and affects the activity and/or stability of all downstream 
signal components (Kim TW and Wang ZY 2010). Therefore our aim 
was to elucidate how BRI1 expression is regulated, and how it can 
influence the developmental and morphogenic processes of plant 
life. Our goals were as follows: 
 
 (1) To determine developmental and organ-specific expression 
patterns of the BRI1 gene using transgenic plants that carry BRI1 
promoter-reporter fusions. 
 (2) To find out how light conditions influence BRI1 activity. 
 (3) To develop a transgenic system for direct monitoring receptor 
distribution by replacing BRI1 with a BRI1-LUC fusion. 
 (4) To characterize the morphogenic effects of targeted ectopic 
expression of BRI1 under the control of well characterized tissue-
specific promoters. 
 
 These studies were expected to clarify the role of BRI1 
expression and abundance in modulating BR sensitivity, and the 
extent to which it can alter developmental effects of the hormone. 
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METHODS 
 
Growth conditions 
 For in vitro cultures surface-sterilized seeds of wild type 
Arabidopsis thaliana ecotype Columbia-0 (Col-0) or its BRI1-deficient 
bri1-101 missense mutant were germinated and grown on solidified 
Murashige-Skoog plant medium, at constant 22°C temperature. 
Seedlings were raised under light/dark conditions (12 h 50-60 µmol 
photons/m2/s fluorescent white light, 12 h dark), or received 
treatments of continuous light or dark. Maintenance and phenotypic 
characterization of the plant lines were done in temperature-
controlled (20-22°C) greenhouse. Following four-five weeks of 
vegetative growth under short day conditions (8 h light/16 h dark), 
the plants were brought to flowering and seed production under long 
day illumination cycles (16 h light/8 h dark). 
 
Generation of transgenic plants 
 Fusion constructs containing either the BRI1 promoter or one of 
three tissue-specific Arabidopsis promoters, plus coding sequences 
of the BRI1 gene and/or the bacterial β-glucuronidase (GUS) or 
firefly luciferase (LUC) reporter genes were assembled in T-DNA-
based binary plant vectors. Transgenic plants carrying the fusion 
genes were generated by Agrobacterium-mediated flower 
transformation of Col-0 or heterozygous bri1-101 plants. Transgenic 
isolates were propagated by self-pollination to produce lines that 
became homozygous for both transgene and genetic background. 
Segregation and gene expression properties of these plants were  
 
4 
 
characterized, and for each transgene construct representative lines 
were chosen for detailed expression or phenotype analyses. 
 
Reporter-based assaying of BRI1 promoter activity 
 BRI1 gene activity was detected via in vitro assaying of GUS 
enzyme activity or in vivo measurement of LUC-generated 
luminescence in BRI1pro:GUS- or BRI1pro:LUC-expressing 
transgenic plants, respectively. The results of GUS histochemical 
staining with X-gluc substrate were evaluated following the removal 
of photosynthetic pigments by ethanol. For measuring LUC activity 
the plants were pre-treated by spraying with luciferin substrate, and 
then the generated luminescence was detected using a high 
sensitivity CCD camera. 
 
Complementation of BRI1-deficiency 
 For rescuing BR-insensitivity of the bri1-101 mutant a fused 
transgene was used, which expresses an easily detectable BRI1-
LUC chimeric protein with fully retained receptor function. The 
effects of complementation by this coding sequence was studied in 
transgenic plant lines that expressed it under the control of the native 
BRI1, the photosynthetic tissue-specific CAB3, or the vasculature-
specific SUC2 and ATHB8 promoters. The morphology of the BRI1-
LUC-expressing lines and the distribution of the chimeric product in 
their organs were analyzed. 
 
Transcript analyses 
 
 Relative levels of the BRI1 and LUC mRNAs were determined by 
real-time RT-PCR analyses. Samples of cDNA were prepared from  
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total RNA isolates using MLV reverse transcriptase and random 
hexanucleotide primers. The RT-PCR reactions were carried out with 
gene-specific oligonucleotide primers, and product accumulation was 
monitored on the basis of increasing SYBR Green fluorescence. The 
measured levels of the transcripts were normalized to those of the 
constitutively expressed TUB2 and TUB3 genes. 
 
Quantitation of the BRI1-LUC fusion protein 
 The relative levels of BR receptor accumulation were determined 
by measuring the luminescence produced by the BRI1-LUC chimeric 
protein expressed in transgenic lines with bri1-101 background. 
Soluble proteins were extracted from different regions of etiolated 
hypocotyls and their LUC activities were measured by luminometer 
upon addition of the luciferin substrate. The detected values were 
normalized to the protein contents of the extracts. 
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RESULTS 
 
 The results of our work can be summarized as follows: 
(1) We generated transgenic Arabidopsis lines expressing the 
BRI1pro:GUS or BRI1pro:LUC reporter genes and used them for 
determining the specificity of BRI1 expression. Our GUS staining 
results revealed differential spatial regulation of the receptor gene, 
and suggested that the sites upregulated BRI1 activity overlap with 
those undergoing BR-dependent morphogenic changes. 
 To clarify if there is indeed correlation between BRI1 expression, 
receptor accumulation and BR sensitivity, we measured the levels of 
the mRNA and receptor protein expressed from the BRI1pro:BRI1-
LUC fusion in a transgenic line where this gene provided the only 
functional BR receptor. Both the transcript and its receptor product 
were seen to accumulate preferentially in the apical half of five-day-
old etiolated hypocotyls. At this developmental stage of dark-grown 
seedlings this part of the hypocotyl is actively elongating. 
Furthermore, this region also shows enhanced expression of multiple 
BR-inducible genes. 
 Our transgenic line carrying the BRI1pro:LUC also allowed the 
monitoring of BRI1 promoter activity in time-course experiments. We 
observed that upon germination BRI1 is strongly induced in both 
light/dark- and dark-grown seedlings, but under light/dark conditions 
its expression level quickly declines after three days. By contrast, the 
activity of the receptor gene remains highly active in continuous dark 
for about one week. This period coincides with the time of elongation 
in etiolated seedlings. 
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 (2) As time-course data showed daily periodicity of BRI1 activity in 
seedlings toward the end of the light/dark measurements, we verified 
this phenomenon in one-week-old BRI1pro:LUC-expressing 
plantlets. In these measurements a biphasic diurnal expression 
pattern was detected, which showed highest activity at the middle of 
the dark phases, but also a much smaller peak in the light periods. 
The sharp increases and decreases of LUC activity were observed 
at lights-on and lights-off, therefore we also tested how the 
expression was affected by light. Under constant light conditions only 
a circadian oscillation pattern could be detected, whereas prolonged 
dark or light treatments caused up- or downregulation, respectively. 
These results showed that the diurnal expression pattern of BRI1 
results from negative light regulation and a superimposed circadian 
effect. 
(3) In order to allow in vivo monitoring of BR receptor production and 
accumulation we generated a transgenic line in which the native 
BRI1 protein is replaced by its LUC-tagged version. To this end the 
promoter and coding sequence of the BRI1 gene was translationally 
fused with the coding region of the LUC reporter, and then this 
chimeric construct was transformed into the bri1-101 mutant 
background. The resulting transgenic lines re-gained their BR 
sensitivity, as could be evidenced by restoration of the wild 
phenotype. The BRI1pro:BRI1-LUC-expressing plants exhibited a 
luminescence pattern that was similar to that of the BRI1pro:LUC 
lines. These results verified that the BRI1-LUC fusion retains its 
receptor function, and confirmed the correlation between the 
induction of the BRI1 gene and the accumulation of its protein 
product. 
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 (4) Our analyses indicated that the BRI1 promoter confers spatial 
and developmental, as well as light-dependent expression to the 
receptor gene. Therefore, we wanted to find out how alterations of 
the optimal expression pattern might affect Arabidopsis growth and 
morphogenesis. With this purpose we prepared gene fusions in 
which the BRI1-LUC coding region was placed under the control of 
well-characterized tissue-specific promoters, and these constructs 
were used as transgenes for ectopic complementation of the bri1-
101 mutant. CAB3 promoter-driven expression, rendering activity in 
all photosynthetic tissues, resulted in almost complete restoration of 
the wild phenotype, with only minor leaf morphology defect that is 
likely caused by local BR hypersensitivity. By contrast, BRI1 
expression from the vascular tissue-specific SUC2 or ATHB8 
promoters had only partial rescuing effect. The SUC2 promoter, 
which is active in the phloem part of the differentiated vasculature, 
produced sufficient BRI1-LUC transcript level for restoring the height 
of the inflorescence, but failed rescuing leaf and silique morphology. 
ATHB8 promoter activity, associated with procambial cells of the 
differentiating vascular bundles, ensured better leaf and silique 
growth, but had weaker effect in the inflorescence stem. These 
experiments clearly demonstrated that proportional organ 
morphogenesis depends on proper, BRI1-promoter-controlled 
expression of the receptor gene. 
 Altogether, our results reveal that BRI1 expression is subject to 
differential regulation at the transcriptional level, and it can influence 
BR sensitivity. This complex control mechanism allows coordination 
between the production of and susceptibility toward BRs, and can be 
instrumental in ensuring optimal effects of the hormone. 
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